Shares of Inari Medical, Inc. (NASDAQ: NARI) surged 12.08% on October 29, 2024, after the medical device company reported impressive third-quarter results and raised its full-year revenue guidance.

For the third quarter ended September 30, 2024, Inari Medical posted revenue of $153.4 million, a 21.4% increase compared to the same period last year. The strong revenue growth was driven by an expansion in sales territories, opening of new accounts, increased adoption of the company's procedures, global commercial expansion, and the introduction of new products. The revenue figure also surpassed analysts' expectations.

Inari Medical raised its full-year 2024 revenue guidance to a range of $601.5 million to $604.5 million, reflecting an increase of $3.5 million at the midpoint from its prior outlook. The company also expects to achieve sustained operating profitability in the first half of 2025, indicating an improved profitability outlook.